Levee Medical

Levee Medical is a clinical-stage medical device company focused on improving surgical outcomes for prostate cancer patients. Based in Durham, NC, the company is currently in the research and development phase, working on a novel urologic device called the Voro prostatectomy implant. This bioresorbable post-prostatectomy implant aims to reduce complications, particularly urinary incontinence, which is a common and debilitating issue following prostate cancer surgery.

Levee Medical's primary clients are healthcare providers and institutions that treat prostate cancer patients. The company operates in the medical device market, specifically targeting the urologic segment. Its business model revolves around developing innovative medical devices that can be licensed or sold to hospitals, clinics, and surgical centers once they receive regulatory approval.

The company recently closed an oversubscribed Series A financing round, raising a total of $6.6 million. These funds will be used to advance product development, scale infrastructure, and expand the team. Levee Medical also raised an additional $4.3 million in oversubscribed funds and successfully treated the first study participants in its initial human study, demonstrating the initial safety of its device.

Levee Medical makes money by developing and eventually selling or licensing its medical devices to healthcare providers. The company is committed to enhancing recovery outcomes for prostate cancer patients, allowing them to return to their daily lives with confidence and minimal complications.

Keywords: prostatectomy, urologic device, medical device, prostate cancer, urinary incontinence, surgical outcomes, bioresorbable implant, clinical-stage, research and development, healthcare providers.